An EU expert panel backed Eli Lilly’s Foundayo application for marketing authorization.
Foundayo is a pill containing orforglipron. The recommendation brings it closer to possible approval in Europe.
Health
Add as a preferred source on GoogleFoundayo Advances in EU Review After Expert Panel Recommendation
Foundayo is a tablet containing orforglipron, and the panel’s backing brings it nearer to possible EU authorization.
Updated 1 min read
Related articles
Health
EMA Panel Confirms Recommendation to Refuse Omeros’ Yartemlea
The application covered adults and children two years and older with a serious stem cell transplant complication; EMA cited gaps in adult and pediatric evidence.
Law
Colorado Proposition 132 Would Expand Fentanyl Penalties and Raise Costs
If approved Nov. 3, the measure would take effect Jan. 1, 2027. The state forecasts $68.2 million in added General Fund spending by its fifth budget year.
Business
Parkview Health to Acquire Ovation, Expanding Its Shared-Services Reach
Ovation says its network includes more than 500 health care organizations in 48 states. The companies expect the transaction to close in the coming weeks, pending review and approvals.